Skip to main content
Premium Trial:

Request an Annual Quote

Own Merits

There are thousands of new research papers examining the coronavirus, and NPR writes that the sheer volume can make it tricky for scientists and others to sort through and vet.

BMJ's Theo Bloom tells NPR one common approach many people use is to look for names of researchers or institutions on the paper they are familiar with and find trustworthy. However, Bloom adds that this approach can reinforce the "'old boys' network" and discount potentially important coronavirus research coming out of China and Europe from researchers and institutions that might not be as well known to US researchers. 

She cautions against the use of those types of markers to indicate quality. "There are retractions and falsifications from great journals, great institutions, from Nobel laureates and so on," Bloom adds at NPR. "So, it behooves us all to try and move away from who we recognize as good."

Instead, researchers tell NPR that the science should be vetted on its own. McGill University's Jonathan Kimmelman, for instance, describes how he compared one research team's stated plan at to what it reported, finding inconsistencies. "It probably took me something between 15 minutes and 30 minutes to come to [the] conclusion that this paper wasn't worth the time of day," he tells NPR.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.